Efficacy and safety of the breast biopsy marker (UltraClip) insertion in patients with breast cancer who undergo neoadjuvant chemotherapy
Not Applicable
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000027267
- Lead Sponsor
- Aichi Cancer Center Hospital Department of Breast oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The patients have a low probability of neoadjvant chemotherapy. The patients is likely to the benign tumor. The patients are judged that the medical attendant was inadequate for this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method False-negative rate in the cCR group
- Secondary Outcome Measures
Name Time Method Stump negative rate Safety of UltraClip The marker insertion rate in the operation group and non cCR group The marker insertion rate in residual tumor in the Non pCR group